Saturday, July 11, 2026

pharma · Premature Birth

PAUL HARTMANN S.P.A

PAUL HARTMANN S.P.A drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

IT HQ
35 Employees
TGA registrant Type
Company details
Status
Public
HQ
IT
Employees
35
Programs
1
Drugs
1
Patents
0
Intelligence · Drug Pipeline

PAUL HARTMANN S.P.A pipeline

Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

PAUL HARTMANN S.P.A drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

1 compounds
  1. Development asset linked to PAUL HARTMANN S.P.A in public FDA and regional records.